# Infantile Hemangioma: Risk Factors and Management in a Preterm Patient—A Case Report

## TL;DR

This case report describes a preterm child with infantile hemangiomas and their successful treatment with propranolol.

## Contribution

The report highlights risk factors, complications, and treatment options for infantile hemangiomas in a preterm patient.

## Key findings

- A preterm child with very low birth weight developed multiple infantile hemangiomas.
- Propranolol oral suspension effectively treated the hemangiomas with no adverse reactions.
- The case emphasizes the importance of early diagnosis and management of infantile hemangiomas.

## Abstract

Infantile hemangiomas (IHs), boasting a prevalence ranging from 4% to 10%, stand as the most commonly encountered benign tumors during the early stages of human life. We present the case of a 2-year-9-month-old child who was born preterm with very low birth weight (VLBW), 1010 g birth weight, at 27 weeks gestational age. During pregnancy, her mother had anemia and needed cervical cerclage. On her 10th day of life, the appearance of a frontal hemangioma could be observed. The hemangioma was situated at the hairline. At the age of one month, another hemangioma could be observed on her right arm. The hemangiomas were treated with propranolol oral suspension for 10 months and afterwards with local ointment for 2 months. This choice of treatment delivered great results, with no adverse reactions reported. In this case report, we underlined the risk factors for IH, possible complications, and available treatment options.